omalizumab chronic rhinosinusitis
Selected indexed studies
- Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. (Int Forum Allergy Rhinol, 2024) [PMID:37394893]
- Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. (Am J Rhinol Allergy, 2022) [PMID:35837739]
- Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. (Lancet Respir Med, 2025) [PMID:41033334]
_Worker-drafted node — pending editorial review._
Connections
omalizumab chronic rhinosinusitis is a side effect of
Sources
- Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. (2022) pubmed
- Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. (2025) pubmed
- Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. (2024) pubmed
- Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence. (2025) pubmed
- Omalizumab for chronic rhinosinusitis. (2018) pubmed
- Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy. (2020) pubmed
- Biologics for chronic rhinosinusitis. (2021) pubmed
- Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps. (2025) pubmed
- PMID:40737467 (2021) pubmed
- Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. (2024) pubmed